6-K ·Filed Aug 26, 2026

IMTX

Immatics N.V.
BEARISH
Impact 6/10
Horizondays Processed1mo ago SEC0001193125-26-368946
Actionable Insight ▼ Bearish

The $161.1M raise provides a substantial cash runway for Immatics' pipeline development, but the ~20%+ dilution (relative to pre-offering share count) creates near-term overhang. Monitor for any pipeline catalysts or partnership announcements that could offset dilution concerns; the stock may trade lower as the market absorbs the new shares.

DirectionBearish
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
IMTX ▼ -11.00% at T+20d
SHORT call ✓ call won +11.00% · α vs SPY +10.50% · entry $9.36 → $8.33
Next anchor: T+60d in 7w
Latest observation: T+24 -3.97% FF3 residual α
Entry anchored
Aug 26, 04:00 PM ET
via 1-min bar
T+1d
+0.96%
call -0.96% · α -1.19%
$9.45
settled 5w ago
T+5d
+1.07%
call -1.07% · α -0.80%
$9.46
settled 4w ago
T+20d
-11.00%
call +11.00% · α +10.50%
$8.33
settled 8d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

Immatics N.V. completed a public offering of 15,535,100 ordinary shares and pre-funded warrants to purchase 4,315,304 ordinary shares, raising approximately $161.1 million in net proceeds. The offering is dilutive to existing shareholders but provides significant cash runway to fund R&D and potential commercialization of its pipeline. The filing is bearish due to the certain present dilution from the share issuance, which outweighs the future-avoided benefit of the pre-funded warrant structure.

Key Facts

  • Immatics completed an offering of 15,535,100 ordinary shares and pre-funded warrants to purchase 4,315,304 ordinary shares.
  • Net proceeds from the offering are approximately $161.1 million.
  • The offering price per share was $8.69, and per pre-funded warrant was $8.689.
  • Underwriters' option to purchase 2,589,814 additional ordinary shares was exercised in full.
  • Proceeds will fund R&D, manufacturing, potential commercialization, and working capital.

Financial Impact

Approximately $161.1 million in net proceeds raised through issuance of 15,535,100 ordinary shares and pre-funded warrants for 4,315,304 shares, representing significant dilution to existing shareholders.

dilutioncash

Risk Factors

  • Significant dilution to existing shareholders from the issuance of 15.5M new shares and potential exercise of pre-funded warrants.
  • Proceeds are for R&D and commercialization, which carry execution risk and no guarantee of near-term revenue.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (IMTX) — Batch item 10001193125-26-368946
Document: 0001193125-26-368946-index-headers.html0001193125-26-368946
Document: 0001193125-26-368946-index.html0001193125-26-368946
Document: 0001193125-26-368946.txt0001193125-26-368946
6-K Filing (IMTX) — Batch item 50001193125-26-368946
16 reports for IMTX
Performance horizon
60% Hit rate 6 of 10 directional calls best @ T+20▲ +22.12%May 12, 2026
Filters
Rows
Reports for IMTX — sortable, filterable
TypeNow
Aug 27, 2026
5w ago
Insider Buy
BULLISH ★ 6/10
$9.45 $8.50▼ −10.05%▼ −10.31%$7.59 (−19.68%)
Aug 26, 2026
5w ago
6-K
BEARISH ★ 6/10
$9.36 $8.33▲ +11.00%▲ +10.50%$7.59 (+18.91%)
Aug 18, 2026
6w ago
6-K
NEUTRAL ★ 6/10
$9.09 $8.82▼ −2.97%▼ −1.98%$7.59 (−16.50%)
Aug 18, 2026
6w ago
Press Release
MIXED ★ 6/10
$9.09 $8.82▼ −2.97%▼ −1.98%$7.59 (−16.50%)
Jun 2, 2026
17w ago
6-K
NEUTRAL ★ 3/10
$10.04 $9.85▼ −1.89%▼ −0.33%$7.59 (−24.40%)
Jun 1, 2026
17w ago
6-K
BULLISH ★ 7/10
$11.14 $10.13▼ −9.07%▼ −7.77%$7.59 (−31.87%)
Jun 1, 2026
17w ago
Press Release
BULLISH ★ 6/10
$11.14 $10.13▼ −9.07%▼ −7.77%$7.59 (−31.87%)
May 31, 2026
17w ago
Press Release
BULLISH ★ 6/10
$11.14 $10.13▼ −9.07%▼ −7.77%$7.59 (−31.87%)
May 30, 2026
17w ago
Press Release
BULLISH ★ 7/10
$11.14 $10.13▼ −9.07%▼ −7.77%$7.59 (−31.87%)
May 12, 2026
20w ago
6-K
BEARISH ★ 6/10
$11.39 $8.87▲ +22.12%▲ +20.40%$7.59 (+33.36%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (65h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access